ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 172 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2015. The put-call ratio across all filers is 1.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $67,000,000 | -21.2% | 1,444,584 | -9.5% | 1.00% | -20.4% |
| Q3 2017 | $85,021,000 | +0.3% | 1,596,334 | +17.0% | 1.26% | +4.0% |
| Q2 2017 | $84,745,000 | +1.0% | 1,364,434 | +10.2% | 1.21% | +2.6% |
| Q1 2017 | $83,900,000 | +1.5% | 1,237,825 | +5.3% | 1.18% | +1.6% |
| Q4 2016 | $82,658,000 | -7.3% | 1,175,616 | -6.5% | 1.16% | -0.8% |
| Q3 2016 | $89,191,000 | +111.2% | 1,257,271 | +45.6% | 1.17% | +138.6% |
| Q2 2016 | $42,229,000 | -30.6% | 863,392 | -10.2% | 0.49% | -25.2% |
| Q1 2016 | $60,850,000 | -51.2% | 961,145 | -13.5% | 0.66% | -47.6% |
| Q4 2015 | $124,695,000 | +3.4% | 1,111,566 | -11.3% | 1.25% | +29.8% |
| Q3 2015 | $120,639,000 | -49.5% | 1,252,614 | -46.3% | 0.96% | -37.4% |
| Q2 2015 | $238,996,000 | +71.5% | 2,334,173 | +4.0% | 1.54% | +102.8% |
| Q1 2015 | $139,374,000 | +138.7% | 2,244,710 | +68.7% | 0.76% | +162.3% |
| Q4 2014 | $58,386,000 | -42.4% | 1,330,567 | -25.7% | 0.29% | -38.1% |
| Q3 2014 | $101,375,000 | +31.0% | 1,791,082 | -0.1% | 0.47% | +50.2% |
| Q2 2014 | $77,393,000 | -5.5% | 1,793,182 | -0.1% | 0.31% | -3.4% |
| Q1 2014 | $81,868,000 | – | 1,795,482 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 38,100 | $2,928,000 | 1.67% |
| Opaleye Management Inc. | 80,000 | $6,149,000 | 1.59% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 410,000 | $31,517,000 | 1.06% |
| Opus Point Partners Management, LLC | 6,311 | $485,000 | 1.05% |
| SECTOR GAMMA AS | 68,015 | $5,228,000 | 0.87% |
| Capital Impact Advisors, LLC | 27,074 | $2,061,000 | 0.76% |
| FORTALEZA ASSET MANAGEMENT INC/ | 1,130 | $87,000 | 0.71% |
| CAPITAL INTERNATIONAL LTD /CA/ | 46,957 | $3,610,000 | 0.63% |
| Virtus ETF Advisers LLC | 8,794 | $676,000 | 0.60% |
| Rock Springs Capital Management LP | 200,000 | $15,374,000 | 0.59% |